Skip to main content
. 2018 Apr 2;2018:4246521. doi: 10.1155/2018/4246521

Figure 2.

Figure 2

End-of-trial changes in HbA1c (%) in the diacerein and placebo groups, stratified by duration of diabetes < 14 (a) or ≥14 years (b), independently of age and gender.